InvestorsObserver
×
News Home

Will Illumina, Inc. (ILMN) Trail the Rest of the Stocks in the Healthcare Sector?

Wednesday, October 05, 2022 01:44 PM | InvestorsObserver Analysts

Mentioned in this article

Will Illumina, Inc. (ILMN) Trail the Rest of the Stocks in the Healthcare Sector?

Illumina, Inc. (ILMN) is near the bottom in its sector according to InvestorsObserver. ILMN gets an overall rating of 65. That means it scores higher than 65% of stocks. Illumina, Inc. gets a 29 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 65
ILMN has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ILMN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Illumina, Inc. Stock Today?

Illumina, Inc. (ILMN) stock is higher by 5.01% while the S&P 500 is lower by -0.35% as of 1:44 PM on Wednesday, Oct 5. ILMN has risen $10.28 from the previous closing price of $205.06 on volume of 1,399,340 shares. Over the past year the S&P 500 has fallen -13.07% while ILMN is lower by -44.50%. ILMN lost -$0.08 per share the over the last 12 months. Click Here to get the full Stock Report for Illumina, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App